Arcus Biosciences Inc (RCUS) earnings · rev $247.0M
These earnings events as JSON? API free 100/dayArcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
This RCUS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported RCUS revenue for 2025-12-31 was $247.0M. Net income was -$353.0M. Revenue was down 4.3% from 2024-12-31 to 2025-12-31. RCUS currently screens at market cap $885.2M.
When the next RCUS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 4.3% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full RCUS research stays on the stock page; the tape stays on the quote page.
RCUS earnings FAQ
What are RCUS's latest revenue and net income?
Latest cached Arcus Biosciences Inc (RCUS) revenue for Dec 31, 2025 was $247.0M. Net income was -$353.0M. Statements: https://lician.com/financials/rcus
What is RCUS's latest diluted EPS?
Latest cached Arcus Biosciences Inc (RCUS) diluted EPS for Dec 31, 2025 was -$3.29.
What period does the latest RCUS earnings print cover?
The latest cached Arcus Biosciences Inc (RCUS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did RCUS revenue change from the prior cached period?
Cached Arcus Biosciences Inc (RCUS) revenue was down 4.3% from $258.0M (Dec 31, 2024) to $247.0M (Dec 31, 2025). Statements: https://lician.com/financials/rcus
Where are RCUS earnings listed?
Cached earnings facts for Arcus Biosciences Inc (RCUS) are listed at https://lician.com/earnings/rcus. Statements: https://lician.com/financials/rcus
Not investment advice.